SSelectStock
Sign in

BLUEJETBlue Jet Healthcare Limited

Pharma · Biotechnology · NSE · as of 2026-07-20 (delayed ~30 min in market hours)

589.50
0.85%
66Decent

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)10,225.80
P/E41.34
P/B7.52
PEG
ROE %19.88
ROCE %19.30
Debt / Equity0.03
EPS14.26
Revenue Growth %-31.10
Profit Growth %-41.50
Dividend Yield %0.20
Promoter Holding %73.14
FII Holding %1.79
DII Holding %
Beta0.77

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

Golden CrossLONG75%589.50496.23776.052.00
Cup & HandleLONG70%589.50565.94707.295.00
HOLDConviction 69%

The picture

  • ROE: 19.9%
  • ROCE: 19.3%
  • Debt/Equity: 0.03
  • RSI: 62
  • Price vs EMA21: above
  • Price vs SMA50: above
  • Cup & Handle signal (setup quality 70%)
  • Golden Cross signal (setup quality 75%)

Bull case

  • ROE: 19.9%
  • ROCE: 19.3%
  • Debt/Equity: 0.03
  • RSI: 62

Bear case

  • Revenue growth: -31.1% YoY
  • Profit growth: -41.5% YoY
  • MACD: bearish
  • Volume: 0.5x 20-day average

Key risks

  • Revenue growth: -31.1% YoY
  • Profit growth: -41.5% YoY

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)
₹589.50
Stop Loss
₹530.60
risk 10%
Target 1 (1.5R)
₹677.84
+15.0%
Target 2 (3R)
₹766.19
+30.0%
Support (20d)
₹508.85
Resistance (52w)
₹1,026.00
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹58.90/share
ATR (volatility)
₹23.56
avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹23.56). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental
56
Technical
70
Momentum
82
Risk (safety)
49

Peers — Pharma

PGHL 0.78%
84
AJANTPHARM 1.45%
82
HESTERBIO 3.09%
81
LUPIN 1.44%
80
SUNPHARMA 1.23%
80
CORONA 0.78%
79

About

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.